- Generic name
- Dobutamine
- Strength
- 250 mg/20 ml
- Dosage form
- Injection
- Manufactured by
- Advanced Chemical Industries PLC
Dobumin Injection
About Dobumin 250 mg/20 ml Injection
Dobumin is a 250 mg/20 ml injection made by Advanced Chemical Industries PLC. It contains dobutamine, a medicine given in hospital to support the heart when its pumping is not enough for the body's needs.
There are 2 brands of Dobutamine listed in Bangladesh.
What is Dobumin 250 mg/20 ml Injection?
Dobumin 250 mg/20 ml injection is manufactured by Advanced Chemical Industries PLC and contains the generic dobutamine. It belongs to a group of medicines called inotropic sympathomimetics. These medicines act on the heart muscle to strengthen its contraction, which can help raise the amount of blood the heart pushes out. Dobumin is given by a healthcare professional, usually in a hospital or critical care setting, when a patient's circulation needs support. Because it is a strong injectable medicine, it is used only under close medical supervision with monitoring of the heart and blood pressure.
Uses of Dobumin
Dobumin is used when inotropic support is needed for patients whose blood flow is poor and whose heart output is not enough to meet the body's circulatory demands. It is also used when such support is required for patients whose heart pumping is abnormally low. Only a doctor can decide whether this injection is suitable for a particular patient, and the dose and course are set by the doctor.
How to use Dobumin
Dobumin injection is prepared and given by a doctor or nurse, not by the patient at home. It is usually given as a controlled infusion into a vein in a hospital or critical care setting. While it is being given, the care team watches the heart rate, heart rhythm and blood pressure closely. The doctor decides the dose, the rate of administration and how long treatment continues, adjusting them to the patient's response.
Side effects of Dobumin
Some patients may have a faster heart rate or a rise in blood pressure during treatment, and extra or premature heartbeats can occur. A sudden fall in blood pressure has occasionally been reported with dobutamine. These effects are usually related to the dose. The care team monitors the patient during the infusion, and if problems appear the doctor may lower the dose or stop the infusion. Anyone noticing unusual symptoms should tell the treating doctor or nurse.
Safety and precautions
Dobumin is given only under medical supervision, with close monitoring of heart rate, rhythm, blood pressure and infusion rate. A doctor should be told about any allergy to dobutamine or to similar medicines, and about other medicines the patient is taking, because some can change how dobutamine works. There are no adequate well-controlled studies in pregnant women, so it should be used in pregnancy only if the potential benefits outweigh the risks to the baby. It is not known whether it passes into breast milk, and breastfeeding is usually stopped during treatment. Ask the doctor about any concerns.
Frequently asked questions
Who should avoid Dobumin or ask the doctor first?
Anyone with a known hypersensitivity to dobutamine should not receive it. Patients with heart rhythm problems, blood pressure problems or other serious conditions, and those taking other heart medicines, should have the doctor review their situation before treatment. Always tell the treating doctor about allergies and all other medicines being taken.
What is Dobumin used for and what kind of medicine is it?
Dobumin is an inotropic sympathomimetic injection. It is used when inotropic support is needed for patients with poor blood flow and heart output that is not enough for the body's circulatory demands, or when heart pumping is abnormally low. It is given by healthcare professionals, and the doctor decides the dose and course.
What does the generic name dobutamine mean?
Dobutamine is the generic name of the active substance in Dobumin. It is a synthetic catecholamine that acts mainly on the heart's beta-adrenergic receptors to strengthen heart muscle contraction. This can increase the amount of blood the heart pumps out. The doctor decides how it is used for each patient.
How is Dobumin given and monitored?
It is given as a controlled infusion into a vein by a doctor or nurse, usually in a hospital or critical care setting. During treatment the care team closely watches heart rate, heart rhythm and blood pressure. The doctor sets the dose, the infusion rate and the length of treatment based on how the patient responds.
Indications
Pharmacology
Dosage & Administration
The rate of administration and the duration of therapy should be adjusted according to the patient's response, The indicators are: haemodynamic parameters such as heart rate and rhythm, arterial pressure, and, whenever possible, cardiac output and measurements of ventricular filling pressures and signs of pulmonary congestion. Concentrations up to 5,000 mg/L have been administered to humans. The final volume administered should be determined by the fluid requirements of the patient. Rather than abruptly discontinuing therapy with Dobutamine Hydrochloride, it is often advisable to decrease the dosage gradually.
Rates of Infusion Based on Concentration of Dobutamine Hydrochloride. The rates of fluid infusion that are required to deliver specific dosages are a function of the concentration of Dobutamine Hydrochloride in the infusate. The following table provides a guideline of infusion rates (mL/kg/min) required for 3 frequently used concentrations of Dobutamine Hydrochloride (250, 500, and 1000 mg/L).
Interaction
There has been no overt indication of medicine interactions in clinical studies in which Dobutamine Hydrochloride was administered concurrently with other medicines, including digitalis preparations, furosemide, spironolactone, lidocaine, nitroglycerin, nitroprusside, isosorbide dinitrate, morphine, atropine, heparin, protamine, potassium chloride, folic acid, and paracetamol.
Contraindications
Side Effects
Hypotension: Precipitous decreases in blood pressure have occasionally been described in association with dobutamine therapy. Decreasing the dose or discontinuing the infusion typically results in rapid return of blood pressure to baseline values. In rare cases, however, intervention may be required and reversibility may not be immediate.
Reactions At Sites Of Intravenous Infusion: Phlebitis has occasionally been reported. Local inflammatory changes have been described following inadvertent infiltration. Isolated cases of cutaneous necrosis (destruction of skin tissue) have been reported.
Miscellaneous Uncommon Effects: The following adverse effects have been reported in 1% to 3% of patients: nausea, headache, anginal pain, nonspecific chest pain, palpitations, and shortness of breath. Isolated cases of thrombocytopenia have been reported.
Administration of dobutamine, like other catecholamines, can produce a mild reduction in serum potassium concentration, rarely to hypokalemic levels.
Longer-Term Safety: Infusions of up to 72 hours have revealed no adverse effects other than those seen with shorter infusions.
Pregnancy & Lactation
It is not known whether this medicine is excreted in human milk. Because many medicines are excreted in human milk, caution should be exercised when Dobutamine Hydrochloride is administered to a nursing woman. If a mother requires dobutamine treatment, breastfeeding should be discontinued for the duration of the treatment.
Precautions & Warnings
Overdose Effects
Treatment: To obtain up-to-date information about the treatment of overdose, a good resource is your certified Regional Poison Control Center. Telephone numbers of certified poison control centers are listed in the Physicians' Desk Reference (PDR). In managing overdosage, consider the possibility of multiple drug overdoses, interaction among drugs, and unusual drug kinetics in your patient.
The initial actions to be taken in a dobutamine hydrochloride overdose are discontinuing administration, establishing an airway, and ensuring oxygenation and ventilation. Resuscitative measures should be initiated promptly. Severe ventricular tachyarrhythmias may be successfully treated with propranolol or lidocaine. Hypertension usually responds to a reduction in dose or discontinuation of therapy.
Protect the patient's airway and support ventilation and perfusion. If needed, meticulously monitor and maintain, within acceptable limits, the patient's vital signs, blood gases, serum electrolytes, etc. If the product is ingested, unpredictable absorption may occur from the mouth and the gastrointestinal tract. Absorption of drugs from the gastrointestinal tract may be decreased by giving activated charcoal, which, in many cases, is more effective than emisis of lavage; consider charcoal instead of or in addition to gastric emptying. Repeated doses of charcoal over time may hasten elimination of some drugs that have been absorbed. Safeguard the patient's airway when employing gastric emptying or charcoal.
Forced diuresis, peritoneal dialysis, hemodialysis, or charcoal hemoperfusion have not been established as beneficial for an overdose of dobutamine hydrochloride.
Storage Conditions
Alternative brands of Dobutamine
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.